X
Edition:
United States

  • Business
    • Business Home
    • Legal
    • Deals
    • Aerospace & Defense
    • Finance
    • Autos
    • Reuters Summits
  • Markets
    • Markets Home
    • U.S. Markets
    • European Markets
    • Asian Markets
    • Global Market Data
    • Indices
    • Stocks
    • Bonds
    • Currencies
    • Comm & Energy
    • Futures
    • Funds
    • Earnings
    • Dividends
  • World
    • World Home
    • U.S.
    • Special Reports
    • Reuters Investigates
    • Euro Zone
    • Middle East
    • China
    • Japan
    • Mexico
    • Brazil
    • Africa
    • Russia
    • India
  • Politics
    • Politics Home
    • Election 2016
    • Polling Explorer
    • Just In
    • What Voters Want
    • Supreme Court
  • Tech
    • Technology Home
    • Science
    • Top 100 Global Innovators
    • Environment
    • Innovation
  • Commentary
    • Commentary Home
    • Podcasts
  • Breakingviews
    • Breakingviews Home
    • Breakingviews Video
  • Money
    • Money Home
    • Retirement
    • Lipper Awards
    • Analyst Research
    • Stock Screener
    • Fund Screener
  • Rio 2016
  • Pictures
    • Pictures Home
    • The Wider Image
    • Photographers
    • Focus 360
  • Video
Embryo-friendly technique produces stem cells
  • Africa
    América Latina
  • عربي
    Argentina
  • Brasil
    Canada
  • 中国
    Deutschland
  • España
    France
  • India
    Italia
  • 日本
    México
  • РОССИЯ
    United Kingdom
  • United States
Science News | Thu Jan 10, 2008 12:59pm EST

Embryo-friendly technique produces stem cells

An image released by Massachusetts-based Advanced Cell Technology on Thursday illustrates a technique to make emryonic stem cells that does not harm human embryos. The company reported on Thursday it has grown five batches of cells using this method and urged President Bush to endorse it. REUTERS/Advanced Cell Technology/Handout
An image released by Massachusetts-based Advanced Cell Technology on Thursday illustrates a technique to make emryonic stem cells that does not harm human embryos. The company reported on Thursday it has grown five batches of cells using this method and urged President Bush... REUTERS/Advanced Cell Technology/Handout
By Maggie Fox, Health and Science Editor | WASHINGTON

WASHINGTON A company that devised a way to make embryonic stem cells using a technique it said does not harm human embryos reported on Thursday it has grown five batches of cells using this method and urged President George W. Bush to endorse it.

Massachusetts-based Advanced Cell Technology has been working with a method sometimes used to test embryos for severe genetic diseases. Called preimplantation genetic diagnosis, it involves taking a single cell from an embryo when it contains only eight or so cells.

The method usually does not harm the embryo, which is frozen for possible future implantation into the mother's womb. The ACT team also froze the embryos and used the single cell that was removed as a source of human embryonic stem cells.

Dr. Robert Lanza, ACT's scientific director, said it provides a way to create mass quantities of embryonic stem cells without harming a human embryo. Current stem cell technologies require the embryo's destruction.

"This is a working technology that exists here and now. It could be used to increase the number of stem cell lines available to federal researchers immediately," Lanza said by e-mail. "We could send these cells out to researchers tomorrow."

Embryonic stem cells are the body's master cells. They can give rise to every other cell type and are found in the earliest-stage embryos.

Researchers agree they could transform medicine. But some people including Bush object to methods that might destroy human embryos, and federal funding for such research is strictly limited.

CELLS FROM SKIN, EGGS

Companies such as ACT can do what they please, and other teams are looking for ways to make ordinary cells act like embryonic stem cells. Three teams of researchers reported progress last year in making what they call induced pluripotent stem cells -- transformed skin cells that look and possibly act like embryonic stem cells.

Another team generated similar cells using human egg cells only, a process called parthenogenesis.

But all the researchers also said scientists must continue to study true embryonic stem cells.

"If the White House approves this new methodology, researchers could effectively double or triple the number of stem cell lines available within a few months. Too many needless deaths continue to occur while this research is being held up," Lanza said.

"I hope the president will act now and approve these stem cell lines quickly."

In a letter to the journal Cell Stem Cell, Lanza and colleagues at the University of California, San Francisco, said they took single cells from five embryos, re-froze the embryos, and used the cells to grow batches of embryonic stem cells.

They thrived in lab dishes, as do true embryonic stem cells, and began to change into the various cell types, Lanza said.

"We discovered a new trick that allowed us to redirect the fate of the removed cell," he said.

"The stem cells we generated were completely normal and differentiated into all the cell types of the body, including insulin-producing cells, blood cells and even beating heart cells."

(Editing by Julie Steenhuysen and Xavier Briand)

Trending Stories

    Editor's Pick

    LIVE: Election 2016

    Sponsored Topics

    Next In Science News

    Piltdown breakdown: new details about a famed scientific hoax

    WASHINGTON Researchers applying modern forensic techniques to a century-old puzzle have laid bare intriguing new details about one of the most notorious scientific hoaxes on record, the so-called Piltdown Man, and are confident in the culprit's identity.

    What3words keeps Olympics visitors on track in Rio

    An innovative addressing system that assigns every patch of earth in the world an easy to remember three-word address is being used to help visitors get around at the Olympics in Rio de Jeneiro. Some 500,000 foreigners are expected to pass through the city during the Games that run until August 21.

    Paralysis partly reversed using brain-machine interface training

    Paraplegic patients recovered partial control and feeling in their limbs after training to use a variety of brain-machine interface technologies, according to new research published on Thursday in the journal "Scientific Reports."

    MORE FROM REUTERS

    From Around the Web By Taboola

    Sponsored Content By Dianomi

    X
    Follow Reuters:
    • Follow Us On Twitter
    • Follow Us On Facebook
    • Follow Us On RSS
    • Follow Us On Instagram
    • Follow Us On YouTube
    • Follow Us On LinkedIn
    Subscribe: Feeds | Newsletters | Podcasts | Apps
    Reuters News Agency | Brand Attribution Guidelines | Delivery Options

    Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:

    Eikon
    Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface
    Elektron
    Everything you need to empower your workflow and enhance your enterprise data management
    World-Check
    Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks
    Westlaw
    Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology
    ONESOURCE
    The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs
    CHECKPOINT
    The industry leader for online information for tax, accounting and finance professionals

    All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

    • Site Feedback
    • Corrections
    • Advertise With Us
    • Advertising Guidelines
    • AdChoices
    • Terms of Use
    • Privacy Policy